Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Reexamination Certificate
2006-03-28
2006-03-28
Housel, James (Department: 1648)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
C424S001210, C424S134100, C424S138100, C424S141100, C424S142100, C424S152100, C424S153100, C530S387100, C530S388230, C530S388100, C530S388240, C530S388250, C435S007100, C435S007200
Reexamination Certificate
active
07018627
ABSTRACT:
The present invention provides purified and isolated polynucleotide sequences encoding a novel macrophage-derived C—C chemokine designated “Macrophage Derived Chemokine” (MDC), and polypeptide fragments and analogs thereof. Also provided are materials and methods for the recombinant or synthetic production of the chemokine, fragments, and analogs; and purified and isolated chemokine protein, and polypeptide fragments and analogs thereof. Also provided are antibodies reactive with the chemokine and methods of making and using all of the foregoing. Also provided are assays for identifying modulators of MDC chemokine activity.
REFERENCES:
patent: 4965392 (1990-10-01), Fritzberg et al.
patent: 5013739 (1991-05-01), Bihari et al.
patent: 5037630 (1991-08-01), Fritzberg et al.
patent: 5179078 (1993-01-01), Rollins et al.
patent: 5241049 (1993-08-01), Goodman et al.
patent: 5278287 (1994-01-01), Rollins et al.
patent: 5413778 (1995-05-01), Kunkel et al.
patent: 5459128 (1995-10-01), Rollins et al.
patent: 5688927 (1997-11-01), Godiska et al.
patent: 5705360 (1998-01-01), Rollins et al.
patent: 5932703 (1999-08-01), Godiska et al.
patent: 6245332 (2001-06-01), Butcher et al.
patent: 6265184 (2001-07-01), Gray et al.
patent: 6268477 (2001-07-01), Gray et al.
patent: 6320023 (2001-11-01), Godiska et al.
patent: 6498015 (2002-12-01), Godiska et al.
patent: 2002/0055147 (2002-05-01), Li et al.
patent: 2002/0098545 (2002-07-01), Li et al.
patent: 0 153 678 (1985-09-01), None
patent: 0 310 136 (1989-04-01), None
patent: 0 317 053 (1989-05-01), None
patent: 0 462 960 (1991-12-01), None
patent: 0 647 447 (1995-04-01), None
patent: 0 666 257 (1995-08-01), None
patent: 0 725 059 (1996-08-01), None
patent: 0 860 446 (1998-08-01), None
patent: WO 89/01046 (1989-02-01), None
patent: WO 91/09955 (1991-07-01), None
patent: WO 92/20808 (1992-11-01), None
patent: WO 94/12650 (1994-06-01), None
patent: WO 95/17092 (1995-06-01), None
patent: WO 96/39521 (1996-12-01), None
patent: WO 96/40923 (1996-12-01), None
patent: WO 97/11969 (1997-04-01), None
patent: WO 96/23068 (1997-08-01), None
patent: WO 97/29192 (1997-08-01), None
patent: WO 97/44055 (1997-11-01), None
patent: WO 97/44462 (1997-11-01), None
patent: WO 98/11226 (1998-03-01), None
patent: WO 95/13295 (1998-05-01), None
patent: WO 98/24907 (1998-06-01), None
patent: WO 98/24908 (1998-06-01), None
patent: WO 01/32128 (2001-05-01), None
Schaniel et al. J. Exp. Med. 1998, vol. 188, pp. 451-463.
Vicari et al. Immunity 1997, vol. 7, pp. 291-301.
Bochner et al. J. Allergy Clinical Immunology 1999, vol. 103, pp. 527-532.
Conrey et al. J Leukoc Biol. 2003, vol. 74, No. 4, pp. 558-563.
Aalbers et al., “Dynamics of Eosinophil Infiltration in the Bronchial Mucosa Before and After the Late Asthmatic Reaction,”Eur. Respir. J.,6:840 (1993).
Abi-Younes, S. et al., “The CC Chemokines MDC and TARC Induce Platelet Activation Via CCR4,”Thromb. Res. 101(4): 278-89 (2001).
Adema, G.J. et al., “A Dendritic-cell-derived C-C Chemokine That Preferentially Attracts Naive T Cells,”Nature, 387:713-717 (Jun. 12, 1997).
Adams, D.O., “The Granulomatous Inflammatory Response,”Am. J. Pathol., 84(1):164-191 (Jul., 1976).
Ahuja et al., “Molecular Evolution of the Human Interleukin-8 Receptor Gene Cluster,”Nature Genetics, 2:31-36 (Sep., 1992).
Amakawa, R. et al., “Impaired Negative Selection of T cells in Hodgekins Disease Antigen CD30-Deficient Mice,” Cell 84: 551-62 (1996).
Aujame, L. et al., “High Affinity Human Antibodies By Phage Display,”Human Antibodies, 8(4):155-168 (1997).
Austrup, F., et al., “P-and E-selectin Mediate Recruitment of T-helper-1 But Not T-helper-2 Cells Into Inflamed Tissues,”Nature 385, 81-83 (1997).
Baba, M. et al., “Identification of CCR6, the Specific Receptor for a Novel Lymphocyte-directed CC Chemokine LARC,”J. Biological Chemistry, 272(23):14893-14898 (Jun. 6, 1997).
Bagglioni et al., “CC Chemokines in Allergic Inflammation,”Immunol. Today 15: 127 (1994).
Baggiolini et al., “Interleukin-8 and Related Chemotactic Cytokines-CXC and CC Chemokines,”Advances in Immunology, 55:97-179 (1994).
Baggiolini, M. et al., “Human Chemokines: An Update,”Annu. Rev. Immunol., 15:675-705 (1997).
Baggiolini, M., et al., “Chemokines and Leukocyte Traffic,” Nature (London), 392:565-68 (1998).
Bai et al., “IL-10 Suppresses Experimental Autoimmune Neuritis and Down-regulates TH1-Type Immune Responses,”Clin. Immunol. Immunopathol., 83(2):117-126 (1997).
Barker et al., “Effects of TH1 and TH2 cytokines on CD8+cell response against human immunodeficiency virus: Implications for long-term survival,”Proc. Natl. Acad. Sci., USA, 92(24):11135-11139 (1995).
Baumer et al., “Th1/Th2 Cell Distribution in Pulmonary Sarcoidosis,”Am. J. Respir. Cell Mol. Biol., 16(2):171-177 (1997).
Beck, L. A., et al., “Cutaneous Injection of RANTES Causes Eosinophil Recruitment: Comparison of Nonallergic and Allergic Human Subjects,”J. Immunol. 159:2962.
Becker et al., “Constitutive and Stimulated MCP-1, GROα, β, and γ Expression in Human Airway Epithelium and Bronchoalveolar Macrophages,”Am. J. Physiol., 266:L278-L288 (1994).
Ben-Baruch, A. et al., “Monocyte Chemotactic Protein-3 (MCP3) Interacts with Multiple Leukocyte Receptors,”J. Biological Chemistry, 270(38):22123-22128 (Sep. 22, 1995).
Berger et al., “Distinct Antigen-induced Cytokine Pattern Upon Stimulation With Antibody-complexed Antigen Consistent With a Th1→Th2-shift,”Res. Virol., 147(2-3):103-108 (1996).
Berin, M.C. et al., “Production of MDC/CCL22 by Human Intestinal Epithelial Cells,” Am. J. Physiol. Gastrointest. Liver Physiol. 280: G1217-G1226 (2001).
Bertoletti et al., “Different Cytokine Profiles of Intrahepatic T Cells in Chronic Hepatitis B and Hepatitis C Virus Infections,”Gastroenterol., 112(1):193-199 (1997).
Bleul, C.C et al., “The Lymphocyte Chemoattractant SDF-1 Is a Ligand for LESTR/fusin and Blocks HIV-1 Entry,”Nature, 382:829-833 (Aug. 29, 1996).
Bochner, B. S., et al., “Adhesion of Human Basophils, Eosinophils and Neutrophils to IT-1-Activated Human Vascular Endothelial Cells: Contributions of Endothelial Cell Adhesion Molecules,” J. Exp. Med. 173: 1553 (1991).
Bombardier et al., “Derivation of the SLEDAI: a Disease Activity Index for Lupus Patients,”Arthritis Rheum, 35:630-40 (1992).
Bonecchi, R. et al., “Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s,”J. Exp. Med., 187(1):129-134 (Jan. 5, 1998).
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,”Science, 247:1306-1310 (1990).
Brown et al., “A Family of Small Inducible Proteins Secreted by Leukocytes are Members of a New Superfamily that Includes Leukocyte and Fibroblast-Derived Inflammatory Agents, Growth Factors, and Indicators of Various Activation Processes,”J. Immunol., 142(2):679-687 (Jan. 15, 1989).
Brown, A.F., “Anaphylactic Shock: Mechanisms and Treatment,”J. Accid. Emerg. Med., 12(2):89-100 (1995).
Brüggemann, M. and Neuberger, “Strategies for expressing human antibody repertoires in transgenic mice,”Immunol. Today, 17(8):391-397 (1996).
Brüggemann, M. and Taussig, “Production of human antibody repertoires in transgenic mice,”Current Opinion Biotechnology, 8:455-458 (1997).
Carballido, J.M. et al., “The Intensity of T Cell Receptor Engagement Determines the Cytokine Pattern of Human Allergen-specific T Helper Cells,”Eur. J. Immunol., 27(2):515-521 (1997).
Cenci et al., “T Helper Cell Type 1 (Th1)-and Th2-like Responses Are Present in Mice with Gastric Candidiasis but Protective Immunity Is Associated with Th1 Development,”J. Infect
Chantry David H.
Deeley Michael C.
Godiska Ronald
Gray Patrick W.
Raport Carol J.
Housel James
Icos Corporation
Li Bao Qun
Marshall & Gerstein & Borun LLP
LandOfFree
Macrophage derived chemokine (MDC), MDC analogs, MDC... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Macrophage derived chemokine (MDC), MDC analogs, MDC..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrophage derived chemokine (MDC), MDC analogs, MDC... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3606015